Milestone Pharmaceuticals is trading 5.08% up now at $1.24, compared with a September 2 close of $1.18, primarily supported by healthcare-sector strength and broader risk-on market conditions.
- No major company-specific catalyst was identified for September 3, 2026.
- The September 2 announcement concerned upcoming investor conferences, without new clinical, regulatory, or financial disclosures.